- Home
- OPBK vs MYO Comparison
OPBK vs MYO Comparison
Compare OPBK & MYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPBK
- MYO
- Stock Information
- Founded
- OPBK 2005
- MYO 2004
- Country
- OPBK United States
- MYO United States
- Employees
- OPBK N/A
- MYO N/A
- Industry
- OPBK Major Banks
- MYO Industrial Specialties
- Sector
- OPBK Finance
- MYO Health Care
- Exchange
- OPBK Nasdaq
- MYO Nasdaq
- Market Cap
- OPBK 213.7M
- MYO 178.4M
- IPO Year
- OPBK 2018
- MYO 2017
- Fundamental
- Price
- OPBK $11.86
- MYO $4.86
- Analyst Decision
- OPBK Hold
- MYO Strong Buy
- Analyst Count
- OPBK 1
- MYO 4
- Target Price
- OPBK $18.00
- MYO $9.75
- AVG Volume (30 Days)
- OPBK 36.0K
- MYO 639.2K
- Earning Date
- OPBK 04-24-2025
- MYO 03-10-2025
- Dividend Yield
- OPBK 3.99%
- MYO N/A
- EPS Growth
- OPBK N/A
- MYO N/A
- EPS
- OPBK 1.39
- MYO N/A
- Revenue
- OPBK $79,278,000.00
- MYO $32,551,198.00
- Revenue This Year
- OPBK $16.70
- MYO $32.15
- Revenue Next Year
- OPBK $12.07
- MYO $17.59
- P/E Ratio
- OPBK $8.65
- MYO N/A
- Revenue Growth
- OPBK N/A
- MYO 69.17
- 52 Week Low
- OPBK $8.91
- MYO $2.51
- 52 Week High
- OPBK $18.57
- MYO $7.17
- Technical
- Relative Strength Index (RSI)
- OPBK 35.93
- MYO 42.63
- Support Level
- OPBK $12.18
- MYO $4.57
- Resistance Level
- OPBK $12.07
- MYO $5.62
- Average True Range (ATR)
- OPBK 0.28
- MYO 0.26
- MACD
- OPBK 0.02
- MYO -0.02
- Stochastic Oscillator
- OPBK 18.52
- MYO 27.62
About OPBK OP Bancorp
OP Bancorp is engaged in the general commercial banking business in Los Angeles, Orange, and Santa Clara Counties, California, Carrollton, Texas, and Las Vegas, Nevada. The Bank is focused on serving the banking needs of small- and medium-sized businesses, professionals, and residents with a particular emphasis on Korean and other ethnic minority communities. It operates with eleven full branches.
About MYO Myomo Inc.
Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA).